Compare Novavax Inc (NVAX) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Novavax Inc trades at $7.95 (market cap $1.30B), while Virgin Galactic Holdings, Inc. trades at $3.3 (market cap $488.94M). The key difference: Novavax Inc is far larger — about 2.7× Virgin Galactic Holdings, Inc.'s market cap, and Novavax Inc is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| NVAX | SPCE | |
|---|---|---|
Market Cap | $1.30B | $488.94M |
Sector | Health | Industrials |
52-Week High | $11.19 | $7.52 |
52-Week Low | $6.22 | $2.17 |
Enterprise Value | $879.40M | $588.79M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
